Page last updated: 2024-12-07

bn 52211

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

BN 52211: a newly synthesized aza alkyl lysophosplipid of MW 536; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID Source	ID
PubMed CID	131968
CHEMBL ID	2001852
SCHEMBL ID	9614165
MeSH ID	M0196439

Synonyms (11)

Synonym
3,5-dioxa-9-aza-4-phosphaheptacosan-1-aminium, 4-hydroxy-7-methoxy-n,n,n,9-tetramethyl-, hydroxide, inner salt, 4-oxide
bn 52211
nsc-643828
9-aza-3, 4-hydroxy- 7-methoxy-9,n,n,n-tetramethyl-, inner salt,4-oxide
choline, 2-methoxy- 3-[methyl(octadecyl)amino]propyl hydrogen phosphate, inner salt
nsc643828
136533-74-9
CHEMBL2001852
SCHEMBL9614165
DTXSID90929458
2-methoxy-3-[methyl(octadecyl)amino]propyl 2-(trimethylazaniumyl)ethyl phosphate

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (4)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	0 (0.00)	18.7374
1990's	4 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.66

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	12.66 (24.57)
Research Supply Index	1.79 (2.92)
Research Growth Index	4.45 (4.65)
Search Engine Demand Index	0.00 (26.88)
Search Engine Supply Index	0.00 (0.95)

This Compound (12.66)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	0 (0.00%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	5 (100.00%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
bn 52205 BN 52205: a synthetic aza alkyl lysophospholipid of MW 436; structure given in first source	2.9	4	0
concanavalin a Concanavalin A: A MANNOSE/GLUCOSE binding lectin isolated from the jack bean (Canavalia ensiformis). It is a potent mitogen used to stimulate cell proliferation in lymphocytes, primarily T-lymphocyte, cultures.	1.98	1	0

Condition	Relationship Strength	Studies
Leucocythaemia [description not available]	1.98	1
Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)	1.98	1
Adenocarcinoma, Basal Cell [description not available]	1.98	1
Cancer of Colon [description not available]	1.98	1
Adenocarcinoma A malignant epithelial tumor with a glandular organization.	1.98	1
Colonic Neoplasms Tumors or cancer of the COLON.	1.98	1

chemdatabank.com